Harvard Bioscience, Inc. - Laporan Laba Rugi (TTM)

Harvard Bioscience, Inc.
DE ˙ DB ˙ US4169061052
€ 0.36 ↓ -0.01 (-1.64%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Harvard Bioscience, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 102 102 105 111 117 119 121 121 118 113 115 114 113 112 107 101 98 94 91 89
Change (%) 0.01 3.15 5.59 5.06 1.77 1.50 0.01 -2.27 -3.92 1.06 -0.39 -1.37 -0.24 -4.87 -5.30 -3.36 -3.68 -2.91 -2.90
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 45 44 45 48 51 51 52 52 53 51 50 50 45 46 44 42 40 39 39 38
Change (%) -1.04 1.75 7.57 5.83 0.43 2.04 -0.52 2.68 -4.44 -1.90 -0.97 -8.30 0.85 -4.12 -5.02 -3.43 -2.49 -0.38 -2.46
% of Revenue 43.61 43.15 42.56 43.36 43.68 43.10 43.33 43.10 45.28 45.04 43.72 43.47 40.41 40.85 41.18 41.30 41.27 41.78 42.86 43.06
Gross Operating Profit 58 58 60 63 66 68 68 69 65 62 64 64 67 66 63 59 57 55 52 51
Change (%) 0.82 4.22 4.13 4.47 2.81 1.10 0.42 -6.02 -3.50 3.48 0.06 3.96 -0.98 -5.38 -5.50 -3.31 -4.51 -4.72 -3.23
% of Revenue 56.39 56.85 57.44 56.64 56.32 56.90 56.67 56.90 54.72 54.96 56.28 56.53 59.59 59.15 58.82 58.70 58.73 58.22 57.14 56.94
SG&A 42 41 41 43 45 47 49 50 51 49 48 47 47 47 46 46 45 44 42 40
Change (%) -1.52 -0.77 5.55 4.28 4.68 4.00 2.11 1.20 -3.59 -1.43 -2.15 -1.28 -0.18 -0.95 -0.97 -2.14 -2.72 -3.93 -5.45
% of Revenue 41.17 40.54 39.00 38.98 38.69 39.80 40.78 41.63 43.11 43.26 42.20 41.46 41.49 41.52 43.23 45.20 45.77 46.23 45.74 44.54
R&D 9 9 9 9 10 11 12 12 12 12 12 11 11 12 12 11 11 10 10 9
Change (%) -3.30 -0.03 9.26 7.50 5.90 6.79 6.90 0.84 -0.82 -2.62 -4.50 -0.03 2.63 -0.10 -2.82 -1.69 -7.32 -5.42 -4.44
% of Revenue 8.80 8.51 8.24 8.53 8.73 9.08 9.55 10.21 10.54 10.88 10.48 10.05 10.19 10.48 11.01 11.29 11.49 11.05 10.77 10.60
OpEx 101 100 100 107 112 115 119 120 123 119 116 114 109 110 108 105 102 99 95 92
Change (%) -1.39 0.48 6.47 5.11 2.62 3.19 1.30 1.84 -3.36 -1.75 -1.83 -4.31 0.33 -1.31 -3.38 -2.51 -3.11 -3.43 -3.56
% of Revenue 99.18 97.79 95.26 96.05 96.10 96.90 98.50 99.78 103.97 104.58 101.68 100.21 97.22 97.78 101.44 103.49 104.39 105.01 104.44 103.73
Operating Income 1 2 5 4 5 4 2 0 -5 -5 -2 -0 3 2 -2 -4 -4 -5 -4 -3
Change (%) 168.65 121.30 -11.99 3.78 -19.01 -51.00 -85.18 -1,848.51 10.80 -62.98 -87.30 -1,382.38 -20.26 -161.44 130.27 21.59 9.88 -13.89 -18.54
% of Revenue 0.82 2.21 4.74 3.95 3.90 3.10 1.50 0.22 -3.97 -4.58 -1.68 -0.21 2.78 2.22 -1.44 -3.49 -4.39 -5.01 -4.44 -3.73
Interest Expense -5 -5 -4 -3 -2 -2 -2 -2 -2 -3 -3 -4 -4 -4 -3 -3 -3 -3 -3 -3
Change (%) -3.73 -18.38 -21.71 -26.95 -31.71 -1.75 9.12 22.77 25.70 23.16 13.58 3.73 -2.87 -6.21 -5.70 -0.82 1.87 1.59 1.29
% of Revenue -4.92 -4.73 -3.74 -2.78 -1.93 -1.30 -1.25 -1.37 -1.72 -2.25 -2.74 -3.12 -3.29 -3.20 -3.15 -3.14 -3.22 -3.41 -3.57 -3.72
Net Income -7 -8 -4 -3 -2 -0 -6 -4 -7 -10 -2 -5 -3 -3 -9 -11 -14 -12 -58 -57
Change (%) 17.53 -49.26 -29.55 -33.24 -84.55 2,156.60 -43.78 88.53 38.13 -78.84 169.56 -39.90 4.66 155.67 22.30 33.37 -12.89 367.96 -1.11
% of Revenue -6.51 -7.65 -3.76 -2.51 -1.60 -0.24 -5.38 -3.03 -5.84 -8.40 -1.76 -4.76 -2.90 -3.04 -8.18 -10.56 -14.57 -13.18 -63.52 -64.68

Source: Capital IQ

Other Listings
US:HBIO US$ 0.48
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista